Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Dredge

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Critical Reviews in Immunology|June 14, 2003
Immunological effects of thalidomide and its chemical and functional analogsKeith Dredge, J Blake Marriott, Angus G Dalgleish
Anti-Cancer Drugs|June 5, 2003
Thalidomide analogs as emerging anti-cancer drugsKeith Dredge, Angus G Dalgleish, J Blake Marriott
Frontiers in Oncology|August 9, 2014
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer TherapeuticsEdward Hammond, Ashwani Khurana, Viji Shridhar, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|July 23, 2003
Thalidomide derived immunomodulatory drugs (IMiDs) as potential therapeutic agentsJ Blake Marriott, Keith Dredge, Angus G Dalgleish
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapyKeith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Molecular Carcinogenesis|July 9, 2011
Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell linesAshwani Khurana, Han W Tun, Laura Marlow, et al.
The Journal of Clinical Investigation|December 10, 2015
Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activationTodd V Brennan, Liwen Lin, Joshua D Brandstadter, et al.
Biochemical Pharmacology|May 4, 2020
Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancerRobert Hoffmann, Sayantani Sarkar Bhattacharya, Debarshi Roy, et al.
Molecular Cancer Therapeutics|May 23, 2013
PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancerKatherine T Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunityKeith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Critical Reviews in Immunology|June 14, 2003
Immunological effects of thalidomide and its chemical and functional analogsKeith Dredge, J Blake Marriott, Angus G Dalgleish
Anti-Cancer Drugs|June 5, 2003
Thalidomide analogs as emerging anti-cancer drugsKeith Dredge, Angus G Dalgleish, J Blake Marriott
Frontiers in Oncology|August 9, 2014
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer TherapeuticsEdward Hammond, Ashwani Khurana, Viji Shridhar, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|July 23, 2003
Thalidomide derived immunomodulatory drugs (IMiDs) as potential therapeutic agentsJ Blake Marriott, Keith Dredge, Angus G Dalgleish
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapyKeith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Molecular Carcinogenesis|July 9, 2011
Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell linesAshwani Khurana, Han W Tun, Laura Marlow, et al.
The Journal of Clinical Investigation|December 10, 2015
Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activationTodd V Brennan, Liwen Lin, Joshua D Brandstadter, et al.
Biochemical Pharmacology|May 4, 2020
Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancerRobert Hoffmann, Sayantani Sarkar Bhattacharya, Debarshi Roy, et al.
Molecular Cancer Therapeutics|May 23, 2013
PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancerKatherine T Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunityKeith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Pageof 4